Recent studies have found that FAM110C is a unique gene that differentiates HBV infection from HBV-associated HCC and is expected to be a novel target for the development and prognosis of HBV-associated HCC (Wang et al., 2021). The gene discussed is FAM110C; the disease is hepatocellular carcinoma.